The FDA's fast track designation aims to expedite ITM-94's development for diagnosing clear cell renal cell carcinoma. The ...
Investigators analyzed biopsy histology from a subset of patients with lupus nephritis treated with obinutuzumab vs placebo in the phase 3 REGENCY trial ...
DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed ...
NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients – – Acute unmet need in R/R ...
Your skin acts as a vital health indicator, with changes like butterfly rashes, velvet plaques, or tripe palms signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback